Fromonot, 240 patient zinc sufficiency study: 89% lower hospitalization [p=0.002] and 28% fewer cases [p=0.003] https://c19p.org/fromonot
copied to clipboard
Hypozincemia in the early stage of COVID-19 is associated with an increased risk of severe COVID-19
et al., Clinical Nutrition, doi:10.1016/j.clnu.2021.04.042
Analysis of 240 consecutive patients in France, showing significantly higher zinc deficiency in COVID-19 patients, and significantly greater risk of hospitalization for COVID-19 patients with zinc deficiency. 2020PI087.
|
risk of hospitalization, 89.2% lower, RR 0.11, p = 0.002, high zinc levels 6 of 110 (5.5%), low zinc levels 7 of 42 (16.7%), NNT 8.9, odds ratio converted to relative risk, within COVID-19 patients.
|
|
risk of case, 27.6% lower, RR 0.72, p = 0.003, high zinc levels 110 of 188 (58.5%), low zinc levels 42 of 52 (80.8%), NNT 4.5.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Fromonot et al., 5/3/2021, prospective, France, Europe, peer-reviewed, 6 authors.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.